Spironolactone And Hydrochlorothiazide

Nephrotic Syndrome, Ascites, Hypokalemia + 14 more
Treatment
18 FDA approvals
20 Active Studies for Spironolactone And Hydrochlorothiazide

What is Spironolactone And Hydrochlorothiazide

SpironolactoneThe Generic name of this drug
Treatment SummaryHydrochlorothiazide is a type of medication used to treat high blood pressure and swelling caused by excess fluid. It is the most commonly prescribed diuretic but is being used less in favor of other medications, such as angiotensin converting enzyme inhibitors. Combination medications are available that contain both hydrochlorothiazide and angiotensin converting enzyme inhibitors or angiotensin II receptor blockers. Hydrochlorothiazide was approved by the FDA in 1959.
Spironolactoneis the brand name
Spironolactone And Hydrochlorothiazide Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Spironolactone
Spironolactone
1960
288

Approved as Treatment by the FDA

Spironolactone, also known as Spironolactone, is approved by the FDA for 18 uses such as Ascites and Hypokalemia .
Ascites
Helps manage Ascites
Hypokalemia
chronic heart failure with reduced ejection fraction (NYHA Class IV)
Helps manage chronic heart failure with reduced ejection fraction (NYHA Class IV)
Swollen feet or ankles
Helps manage Edema
Cirrhosis of the Liver
Helps manage Cirrhosis of the Liver
Primary Hyperaldosteronism
Helps manage Primary Hyperaldosteronism
idiopathic hyperaldosteronism
Helps manage idiopathic hyperaldosteronism
Congestive Heart Failure (CHF)
Helps manage Congestive Heart Failure (CHF)
Hypesthesia
Helps manage chronic heart failure with reduced ejection fraction (NYHA Class IV)
Edema
Helps manage Edema
Hypesthesia
Helps manage chronic heart failure with reduced ejection fraction (NYHA Class III)
Cirrhosis
Helps manage Cirrhosis of the Liver
Hyperaldosteronism
Helps manage Primary Hyperaldosteronism
Nephrotic Syndrome
Helps manage Nephrotic Syndrome
Congestive Heart Failure
Helps manage Congestive Heart Failure (CHF)
Hypertensive disease
Helps manage High Blood Pressure (Hypertension)
Ascites
Helps manage Ascites
Hyperaldosteronism
Helps manage idiopathic hyperaldosteronism

Effectiveness

How Spironolactone And Hydrochlorothiazide Affects PatientsHydrochlorothiazide helps the body get rid of extra water by blocking the kidneys from absorbing too much salt and water. Everyone's individual dose can range from 25-100mg. It is important to be cautious when taking this drug if you have any issues with your kidneys or liver.
How Spironolactone And Hydrochlorothiazide works in the bodyHydrochlorothiazide works by blocking a protein in the kidneys called SLC12A3, which helps the body to reabsorb sodium and chloride. This protein also helps to reabsorb water. When hydrochlorothiazide blocks this protein, it reduces the amount of sodium and chloride that is reabsorbed, and also reduces the amount of water being reabsorbed. This leads to increased urination and helps to lower blood pressure.

When to interrupt dosage

The measure of Spironolactone And Hydrochlorothiazide is subject to the diagnosed condition, including Antepartum magnesium sulfate counteractive measure, blood pressure inadequately controlled with monotherapy and antihypertensives. The dosage varies as indicated by the technique of delivery (e.g. Tablet, coated - Oral or Oral) featured in the table underneath.
Condition
Dosage
Administration
Nephrotic Syndrome
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Ascites
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hypokalemia
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Acne Vulgaris
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hyperaldosteronism
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hyperaldosteronism
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Swollen feet or ankles
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hypesthesia
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hypesthesia
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Congestive Heart Failure
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hirsutism
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hypertensive disease
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hyperaldosteronism
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Cirrhosis
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Edema
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
Hypertension
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated
inadequate response to other therapeutic measures
50.0 mg, , 100.0 mg, 25.0 mg, 25.0 mg/mL, 0.02 mg/mg, 0.05 mg/mg
, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Suspension, Suspension - Oral, Topical, Gel - Topical, Gel, Tablet, coated - Oral, Tablet, coated

Warnings

Spironolactone And Hydrochlorothiazide has two contraindications, so it should not be consumed when dealing with any of the conditions shown in the accompanying table.Spironolactone And Hydrochlorothiazide Contraindications
Condition
Risk Level
Notes
Renal Insufficiency
Do Not Combine
Anuria
Do Not Combine
Acute Kidney Injury
Do Not Combine
Hyperkalemia
Do Not Combine
Pulse Frequency
Do Not Combine
Addison Disease
Do Not Combine
There are 20 known major drug interactions with Spironolactone And Hydrochlorothiazide.
Common Spironolactone And Hydrochlorothiazide Drug Interactions
Drug Name
Risk Level
Description
Amiodarone
Major
The metabolism of Amiodarone can be decreased when combined with Spironolactone.
Brigatinib
Major
The metabolism of Brigatinib can be decreased when combined with Spironolactone.
Cabazitaxel
Major
The metabolism of Cabazitaxel can be decreased when combined with Spironolactone.
Cyclosporine
Major
The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cyclosporine.
Dabrafenib
Major
The metabolism of Dabrafenib can be decreased when combined with Spironolactone.
Spironolactone And Hydrochlorothiazide Toxicity & Overdose RiskThe lowest toxic dose of hydrochlorothiazide in mice and rats has been found to be greater than 10g/kg. Those who overdose may experience low potassium, chloride, and sodium levels. Treatment for an overdose includes fluids and electrolytes, as well as vasopressors to treat low blood pressure, and oxygen if breathing is impaired.
image of a doctor in a lab doing drug, clinical research

Spironolactone And Hydrochlorothiazide Novel Uses: Which Conditions Have a Clinical Trial Featuring Spironolactone And Hydrochlorothiazide?

158 active studies are examining the potential of Spironolactone And Hydrochlorothiazide in providing relief from Cirrhosis, Edema and Congestive Heart Failure.
Condition
Clinical Trials
Trial Phases
Cirrhosis
52 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Phase 3, Phase 4, Early Phase 1
Hypesthesia
8 Actively Recruiting
Not Applicable, Phase 1
Ascites
2 Actively Recruiting
Not Applicable, Phase 2
Nephrotic Syndrome
5 Actively Recruiting
Phase 2, Not Applicable, Phase 3
Hypertension
0 Actively Recruiting
Congestive Heart Failure
11 Actively Recruiting
Not Applicable, Phase 1, Phase 2
Hirsutism
0 Actively Recruiting
Hypokalemia
0 Actively Recruiting
Acne Vulgaris
0 Actively Recruiting
Hyperaldosteronism
0 Actively Recruiting
inadequate response to other therapeutic measures
0 Actively Recruiting
Hyperaldosteronism
0 Actively Recruiting
Hypertensive disease
27 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3
Swollen feet or ankles
5 Actively Recruiting
Phase 2, Not Applicable, Phase 4
Hypesthesia
4 Actively Recruiting
Not Applicable, Phase 1
Hyperaldosteronism
0 Actively Recruiting
Edema
0 Actively Recruiting

Spironolactone And Hydrochlorothiazide Reviews: What are patients saying about Spironolactone And Hydrochlorothiazide?

5Patient Review
8/24/2009
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I had no idea that this medication didn't include a diuretic. I'm glad I found this website so that I could learn more about what I'm taking and why.
5Patient Review
11/7/2007
Spironolactone And Hydrochlorothiazide for High Blood Pressure
5Patient Review
1/3/2013
Spironolactone And Hydrochlorothiazide for High Blood Pressure
This medication has helped me a lot with my nocturnal leg cramps.
4.7Patient Review
12/23/2014
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I accidentally took two doses today. What should I do?
4.3Patient Review
2/6/2017
Spironolactone And Hydrochlorothiazide for High Blood Pressure
At first, I had to go to the restroom more often after taking this pill at night. However, about a month and a half later, I started feeling dizzy during my workouts. Once I reduced the intensity of my workout regime, the lightheadedness went away.
4Patient Review
5/12/2009
Spironolactone And Hydrochlorothiazide for Visible Water Retention
This medication caused my potassium levels to drop drastically, to the point where I am now exhausted and weak. I've also lost a lot of weight, which is alarming considering I only weigh 124lbs on my heavy days.
4Patient Review
8/1/2018
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I found this drug to be effective for me.
3.7Patient Review
2/27/2008
Spironolactone And Hydrochlorothiazide for High Blood Pressure
Spirono/HCTZ has been a godsend for me. Without it, my body retains so much water that my skin stretches tight and looks like it might split.
3Patient Review
2/21/2011
Spironolactone And Hydrochlorothiazide for Accumulation of Fluid caused by Cirrhosis of the Liver
The main side effect I've noticed is needing to use the restroom very urgently. This has led to some embarrassing situations, like today at the grocery store. I had been noticing my hair getting thicker since I quit drinking, but now it seems to be thinning out again. If anyone else has experienced this with regards to bladder control and hair loss, please let me know. Some advice would be much appreciated.
3Patient Review
3/10/2018
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I was on this medication for two months before having some routine blood tests taken. Unfortunately, these results showed that I had developed renal failure and so my doctor took me off the medication.
3Patient Review
5/12/2009
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I was prescribed this medication after my blood pressure started to rise. I'm glad that it is a single pill that addresses both low potassium and high blood pressure, as I have a tendency towards low potassium levels.
3Patient Review
11/10/2009
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I've only been on this medication for six months, but my blood pressure has already gone down to a normal level. I have not experienced any side effects yet, which is great. However, I did read that hair loss is a potential side effect of this drug and I am wondering if anyone else has had this problem?
2.7Patient Review
12/31/2008
Spironolactone And Hydrochlorothiazide for High Blood Pressure
Does this medication make you feel dizzy?
1.7Patient Review
2/4/2010
Spironolactone And Hydrochlorothiazide for High Blood Pressure
Not at all effective for treating my blood pressure. Also, I experienced morning stomach upset and extreme erectile dysfunction. Overall, this treatment was not helpful to me whatsoever.
1.7Patient Review
8/16/2017
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I only took this drug sporadically at first, but when I started taking it more regularly is when I began to feel odd and anxious. I couldn't sleep because of how anxious I felt. These are the same symptoms I experience when taking sulfa drugs.
1.7Patient Review
5/9/2011
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I felt dizzy and lightheaded after taking this medication.
1.3Patient Review
11/24/2013
Spironolactone And Hydrochlorothiazide for High Blood Pressure
I started to experience itching after only a few days of use, which increased in frequency and intensity over time. I also found myself feeling dizzy and needing to urinate more frequently. Ultimately, the side effects were too much for me to continue taking this medication.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about spironolactone and hydrochlorothiazide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What medications should not be taken with hydrochlorothiazide?

"The following drugs may have a negative interactions with hydrochlorothiazide: barbiturates, lithium, blood pressure drugs, cholesterol-lowering drugs, corticosteroids, diabetes drugs, narcotics, and nonsteroidal anti-inflammatory drugs (NSAIDs)."

Answered by AI

Which is better hydrochlorothiazide or spironolactone?

"Spironolactone is a better option than hydrochlorothiazide for blood pressure control and improving arterial stiffness."

Answered by AI

Are spironolactone and hydrochlorothiazide the same thing?

"Hydrochlorothiazide and spironolactone are two drugs that are often given together to help treat fluid retention. Hydrochlorothiazide is a thiazide diuretic, while spironolactone is a potassium-sparing diuretic. These two drugs work together to help reduce fluid retention and improve kidney function."

Answered by AI

Can losartan hydrochlorothiazide and spironolactone be taken together?

"If you take spironolactone and losartan at the same time, it could raise your potassium levels. If potassium gets too high, it can cause hyperkalemia, which can be deadly. Symptoms of hyperkalemia include kidney failure, muscle paralysis, and an irregular heartbeat."

Answered by AI

Clinical Trials for Spironolactone And Hydrochlorothiazide

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Waitlist Available
Has No Placebo
U Health (+1 Sites)Ziad Zoghby, M.D., M.B.A.Biobeat Technologies Ltd.
Image of Cedars-Sinai Medical Center in Los Angeles, United States.

AI-Enabled Identification for Fatty Liver Disease

18+
All Sexes
Los Angeles, CA
The goal of this prospective, multicenter, open-label, blinded end-point pragmatic study is to evaluate an artificial intelligence (AI)-augmented echocardiography screening approach for early detection of metabolic dysfunction associated steatotic liver disease (MASLD) and/or cirrhosis, in patients undergoing routine transthoracic echocardiograms (TTEs). The main question it aims to answer is to: 1. Evaluate notification responsiveness and rates of confirmatory testing for patients identified as high risk for having liver disease to determine whether optimized notifications increase timely confirmatory testing and treatment initiation versus standard of care assessment. 2. Compare time to diagnosis, treatment uptake, and clinical outcomes (hospitalizations, incident ASCVD, mortality) between cohorts identified as high risk by the AI algorithm and comparison groups to determine whether AI guided screening shortens time to diagnosis and increases appropriate treatment.
Waitlist Available
Has No Placebo
Cedars-Sinai Medical Center (+3 Sites)
Have you considered Spironolactone And Hydrochlorothiazide clinical trials? We made a collection of clinical trials featuring Spironolactone And Hydrochlorothiazide, we think they might fit your search criteria.Go to Trials
Image of University of Alabama at Birmingham in Birmingham, United States.

Dietary Interventions for Hypertension

18+
All Sexes
Birmingham, AL
Natriuretic peptides (NPs) are hormones produced by the heart and play an important role in maintaining cardiovascular health and have favorable metabolic benefits. Low NP levels are associated with an increased likelihood of the development of cardiometabolic diseases like diabetes and hypertension. NP levels are known to be highly heritable, with up to half of the differences in NP levels being explained by genetics. The investigators aim to describe the genetic architecture of NPs by examining the genetic variants associated with NPs, and generate and validate a polygenic score (PGS) for NPs. The investigators will use this NP PGS to examine the association of genetically determined NP levels with cardiometabolic and cardiovascular outcomes. The investigators will conduct a genotype-guided physiological clinical trial that aims to assess the genetic factors affecting NP levels and their impact on blood pressure and NP response to saline infusion, high-salt diet, and low-salt diet. These findings will help support personal medicine approaches to lower the increasing burden of hypertension in the United States.
Waitlist Available
Has No Placebo
University of Alabama at BirminghamPankaj Arora, MD, FAHA
Image of Cleveland Clinic Main Campus in Cleveland, United States.

Metabolic Surgery and TIPS for Liver Cirrhosis

18 - 70
All Sexes
Cleveland, OH
Cirrhosis is a form of advanced liver disease that can lead to serious complications, especially when combined with severe obesity. Many patients with cirrhosis also develop a condition called clinically significant portal hypertension (CSPH), which is increased pressure in the veins of the liver. CSPH raises the risk of life-threatening events like internal bleeding and liver failure. Unfortunately, treatment options for people who have both cirrhosis and severe obesity are very limited, especially when portal hypertension is present. This study, called the OPTIMAL Trial, is a randomized clinical trial designed to evaluate whether combining two procedures improves health outcomes in this high-risk population. The first procedure, called TIPS (Transjugular Intrahepatic Portosystemic Shunt), is a minimally invasive treatment that reduces pressure in the liver by creating a pathway for blood to flow more easily. The second procedure is sleeve gastrectomy, a form of metabolic (bariatric) surgery that helps patients lose weight and improve related conditions like diabetes. The study will compare two groups: 1. One group will receive TIPS followed by sleeve gastrectomy (TIPS+SG). 2. The other group will receive medical weight management (standard non-surgical care, including diet, lifestyle changes, and weight loss medications). All participants will have severe obesity and cirrhosis with CSPH but will not have decompensated liver disease (such as large amounts of fluid in the abdomen, a history of variceal bleeding, or recent liver failure). Eligible participants will be randomly assigned to one of the two groups. The main goal of the study is to determine whether the combination of TIPS + SG improves quality of life and leads to greater weight loss compared to medical therapy alone. The study will also monitor for any complications from either the procedures or the medical treatment. Participants will be followed for 6 months after their treatment starts, with periodic assessments of their physical health, liver function, and overall well-being. Some participants may also be followed for a longer period to assess long-term outcomes. This study hopes to provide high-quality evidence for a novel, stepwise treatment strategy that may help people with obesity and liver disease live longer, healthier lives. If successful, it could change how advanced liver disease and obesity are managed together, especially in patients who currently have few safe and effective options. All study care is provided at Cleveland Clinic, Cleveland, Ohio, USA.
Phase 4
Recruiting
Cleveland Clinic Main CampusSobia Laique, MD
Image of NewYork-Presbyterian/Weill Cornell Medical Center in New York, United States.

Melatonin for Liver Cirrhosis

18+
All Sexes
New York, NY
The goal of this clinical trial is to learn the affect of melatonin on sleep, cognitive function, and quality of life (QoL) in patients with cirrhosis and a complication called hepatic encephalopathy (HE). The main questions this study aims to answer are: * Does taking melatonin increase REM sleep, an important part of healthy sleep that is reduced in cirrhosis? * Does taking melatonin improve cognitive function and reported QoL? This is a pilot study, where participants will: * take one month of melatonin, followed by one month of thiamine, which is another supplement but is not suspected to impact sleep significantly. * Undergo cognitive testing and take surveys * Wear a commercial wearable sleep tracker * Have a formal sleep study and salivary melatonin collection at the end of taking each supplement at our sleep center Participants will be blinded, and neither they nor the researchers will know which supplement they are taking first and which they are taking second. They will also be randomized, with half starting with melatonin and the other half starting with thiamine.
Recruiting
Has No Placebo
NewYork-Presbyterian/Weill Cornell Medical CenterAdam Buckholz, MD MS
Have you considered Spironolactone And Hydrochlorothiazide clinical trials? We made a collection of clinical trials featuring Spironolactone And Hydrochlorothiazide, we think they might fit your search criteria.Go to Trials
Image of Virginia Commonwealth University in Richmond, United States.

Endovascular Treatment for Stroke

18+
All Sexes
Richmond, VA
Endovascular therapy (EVT) has proven to be more beneficial for patients with AIS caused by large vessel occlusions (LVO) than medical management alone. A recent meta-analysis of 5 RCTs showed that EVT significantly reduced disability at 90 days compared to medical management \[1\]. Despite its obvious benefits, patients may have neurological deterioration despite successful thrombectomy due to ischemia progression, intracranial hemorrhage, re-occlusion, or vasogenic edema. The incidence of early neurological deterioration (END) following EVT for acute stroke has been reported to be ranging from 14.1-35.2% with some studies defining END up to 7 days and some restricting the definition between 6-72 hours post thrombectomy. A small proportion of these patients, approximately 5.9-10.5%, experienced sICH following EVT. Whether END occurs due to ischemic or hemorrhagic it leads to worse outcomes.
Waitlist Available
Has No Placebo
Virginia Commonwealth UniversityAarti Sarwal
Image of Future Life Clinical Trials in Miami, United States.

Extended vs Immediate Release Torsemide for Heart Failure

18+
All Sexes
Miami, FL
The primary objective of this study is to learn whether a morning dose of extended-release torsemide enhances renal sodium excretion after lunch (4-8 hours after dosing) compared to immediate-release torsemide. This is a randomized, double-blind, crossover study in patients with heart failure who are on a stable dose of a loop diuretic. During the study period, participants' current loop diuretics will be replaced with an equivalent dose of either immediate-release or extended-release torsemide. Following a one-week stabilization period on the assigned torsemide formulation, patients will report to the clinical site for an assessment visit. On the study day, patients will take a single dose of the same torsemide formulation they have been on for the past week, administered after breakfast. Urine samples be collected are: * 0-4 hours post-dosing (pre-lunch period) * 4-8 hours post-dosing (post-lunch period) * 8-24 hours post-dosing (24 hours period) The primary endpoint will be urinary sodium excretion (4-8 hours after dosing). This will be compared between the extended-release arm and the immediate-release arm to assess the efficacy of prolonged diuretic action. In addition, urinary potassium and creatinine excretion and creatinine clearance will be measured in all urine samples as the safety endpoints.
Phase 4
Recruiting
Future Life Clinical TrialsSalim Shah, PhD, JDSarfez Pharmaceuticals, Inc.
Have you considered Spironolactone And Hydrochlorothiazide clinical trials? We made a collection of clinical trials featuring Spironolactone And Hydrochlorothiazide, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security